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background: We sought to determine the prognostic utility of brain natriuretic peptide (BNP) levels in patients with significant aortic stenosis (AS).
methods: We studied 619 AS patients (72±12 years, 56% men) who had an echo with an aortic valve area (AVA) ≤ 1.3cm2, left ventricular 
ejection fraction (LVEF) ≥ 50% & BNP measured between 1/07-12/08 at our center (excluding severe other valve disease). Clinical & echo data was 
recorded. BNP (pg/ml) levels were divided into quartiles: 1st quartile (q) (0-62) n=193, 2nd q (63-138) n=180, 3rd q (139-311) n= 151 & 4th q 
(>311) n=95. All-cause mortality was recorded.
results: Functional class (FC) was distributed as follows: I (23%), II (42%), III (27%) & IV (7%). Mean LVEF & AVA were 58±5 mm Hg & 0.8±0.2 
cm2. At 4.5±1.8 years, 443 (72%) had AV replacement; 171 (28%) patients died. On time-dependent survival analysis, increasing Euroscore (Hazard 
Ratio or HR 1.07 [1.02-1.12]), FC (HR 1.40 [1.18-1.67]) & BNP (HR 1.07 [1.04-1.09], for every 100pg/ml increase) predicted increased mortality 
while AV surgery (HR 0.56 [-.41--.78]) improved survival (all p<0.001). Mortality in BNP quartiles was as follows: 1st (22 [11%]), 2nd (49 [27%]), 
3rd (46 [31%]) and 4th (54 [57%]). Figure A shows survival curves based on BNP quartiles. Figure B shows incremental value of BNP in predicting 
mortality over clinical variables.
conclusions: In AS patients with preserved LVEF, elevated BNP is an independent predictor of mortality, providing incremental value to clinical 
variables.
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